| Cancer-type | Pathway | Q-value | P-value | Pathway size | Cancer set size | DP | DN | GP | GN |
| Ley_leukemia | hsa05221:Acute myeloid leukemia | 1 | 0.0516 | 84 | 2 | 1 | 1 | 84 | 3164 |
| Ley_leukemia | hsa04640:Hematopoietic cell lineage | 1 | 0.0534 | 87 | 2 | 1 | 1 | 87 | 3161 |
| Ley_leukemia | hsa04520:Adherens junction | 1 | 0.069 | 113 | 2 | 1 | 1 | 113 | 3135 |
| Ley_leukemia | hsa04670:Leukocyte transendothelial migration | 1 | 0.0808 | 133 | 2 | 1 | 1 | 133 | 3115 |
| Ley_leukemia | hsa04060:Cytokine-cytokine receptor interaction | 1 | 0.142 | 239 | 2 | 1 | 1 | 239 | 3009 |
| Ley_leukemia | hsa05050:Dentatorubropallidoluysian atrophy (DRPLA) | 1 | 1 | 18 | 2 | 0 | 2 | 18 | 3230 |
| Ley_leukemia | hsa04710:Circadian rhythm | 1 | 1 | 14 | 2 | 0 | 2 | 14 | 3234 |
| Ley_leukemia | hsa04320:Dorso-ventral axis formation | 1 | 1 | 44 | 2 | 0 | 2 | 44 | 3204 |
| Ley_leukemia | hsa05010:Alzheimer's disease | 1 | 1 | 33 | 2 | 0 | 2 | 33 | 3215 |
| Ley_leukemia | hsa04130:SNARE interactions in vesicular transport | 1 | 1 | 33 | 2 | 0 | 2 | 33 | 3215 |
| Ley_leukemia | hsa03050:Proteasome | 1 | 1 | 22 | 2 | 0 | 2 | 22 | 3226 |
| Ley_leukemia | hsa05040:Huntington's disease | 1 | 1 | 37 | 2 | 0 | 2 | 37 | 3211 |
| Ley_leukemia | hsa04330:Notch signaling pathway | 1 | 1 | 50 | 2 | 0 | 2 | 50 | 3198 |
| Ley_leukemia | hsa05223:Non-small cell lung cancer | 1 | 1 | 90 | 2 | 0 | 2 | 90 | 3158 |
| Ley_leukemia | hsa05216:Thyroid cancer | 1 | 1 | 35 | 2 | 0 | 2 | 35 | 3213 |
| Ley_leukemia | hsa03022:Basal transcription factors | 1 | 1 | 29 | 2 | 0 | 2 | 29 | 3219 |
| Ley_leukemia | hsa04012:ErbB signaling pathway | 1 | 1 | 196 | 2 | 0 | 2 | 196 | 3052 |
| Ley_leukemia | hsa05220:Chronic myeloid leukemia | 1 | 1 | 135 | 2 | 0 | 2 | 135 | 3113 |
| Ley_leukemia | hsa05214:Glioma | 1 | 1 | 98 | 2 | 0 | 2 | 98 | 3150 |
| Ley_leukemia | hsa01510:Neurodegenerative Diseases | 1 | 1 | 59 | 2 | 0 | 2 | 59 | 3189 |
| Ley_leukemia | hsa05213:Endometrial cancer | 1 | 1 | 78 | 2 | 0 | 2 | 78 | 3170 |
| Ley_leukemia | hsa04110:Cell cycle | 1 | 1 | 166 | 2 | 0 | 2 | 166 | 3082 |
| Ley_leukemia | hsa03020:RNA polymerase | 1 | 1 | 15 | 2 | 0 | 2 | 15 | 3233 |
| Ley_leukemia | hsa05215:Prostate cancer | 1 | 1 | 125 | 2 | 0 | 2 | 125 | 3123 |
| Ley_leukemia | hsa05212:Pancreatic cancer | 1 | 1 | 125 | 2 | 0 | 2 | 125 | 3123 |
| Ley_leukemia | hsa04664:Fc epsilon RI signaling pathway | 1 | 1 | 114 | 2 | 0 | 2 | 114 | 3134 |
| Ley_leukemia | hsa03030:DNA polymerase | 1 | 1 | 22 | 2 | 0 | 2 | 22 | 3226 |
| Ley_leukemia | hsa05219:Bladder cancer | 1 | 1 | 64 | 2 | 0 | 2 | 64 | 3184 |
| Ley_leukemia | hsa04662:B cell receptor signaling pathway | 1 | 1 | 76 | 2 | 0 | 2 | 76 | 3172 |
| Ley_leukemia | hsa04210:Apoptosis | 1 | 1 | 120 | 2 | 0 | 2 | 120 | 3128 |
| Ley_leukemia | hsa04115:p53 signaling pathway | 1 | 1 | 64 | 2 | 0 | 2 | 64 | 3184 |
| Ley_leukemia | hsa05130:Pathogenic Escherichia coli infection - EHEC | 1 | 1 | 82 | 2 | 0 | 2 | 82 | 3166 |
| Ley_leukemia | hsa05131:Pathogenic Escherichia coli infection - EPEC | 1 | 1 | 82 | 2 | 0 | 2 | 82 | 3166 |
| Ley_leukemia | hsa05060:Prion disease | 1 | 1 | 13 | 2 | 0 | 2 | 13 | 3235 |
| Ley_leukemia | hsa04660:T cell receptor signaling pathway | 1 | 1 | 117 | 2 | 0 | 2 | 117 | 3131 |
| Ley_leukemia | hsa05211:Renal cell carcinoma | 1 | 1 | 102 | 2 | 0 | 2 | 102 | 3146 |
| Ley_leukemia | hsa04720:Long-term potentiation | 1 | 1 | 90 | 2 | 0 | 2 | 90 | 3158 |
| Ley_leukemia | hsa05218:Melanoma | 1 | 1 | 83 | 2 | 0 | 2 | 83 | 3165 |
| Ley_leukemia | hsa05210:Colorectal cancer | 1 | 1 | 123 | 2 | 0 | 2 | 123 | 3125 |
| Ley_leukemia | hsa05020:Parkinson's disease | 1 | 1 | 21 | 2 | 0 | 2 | 21 | 3227 |
| Ley_leukemia | hsa04620:Toll-like receptor signaling pathway | 1 | 1 | 125 | 2 | 0 | 2 | 125 | 3123 |
| Ley_leukemia | hsa05030:Amyotrophic lateral sclerosis (ALS) | 1 | 1 | 21 | 2 | 0 | 2 | 21 | 3227 |
| Ley_leukemia | hsa04370:VEGF signaling pathway | 1 | 1 | 92 | 2 | 0 | 2 | 92 | 3156 |
| Ley_leukemia | hsa04150:mTOR signaling pathway | 1 | 1 | 53 | 2 | 0 | 2 | 53 | 3195 |
| Ley_leukemia | hsa05222:Small cell lung cancer | 1 | 1 | 120 | 2 | 0 | 2 | 120 | 3128 |
| Ley_leukemia | hsa04350:TGF-beta signaling pathway | 1 | 1 | 124 | 2 | 0 | 2 | 124 | 3124 |
| Ley_leukemia | hsa05120:Epithelial cell signaling in Helicobacter pylori infection | 1 | 1 | 73 | 2 | 0 | 2 | 73 | 3175 |
| Ley_leukemia | hsa04510:Focal adhesion | 1 | 1 | 262 | 2 | 0 | 2 | 262 | 2986 |
| Ley_leukemia | hsa04910:Insulin signaling pathway | 1 | 1 | 148 | 2 | 0 | 2 | 148 | 3100 |
| Ley_leukemia | hsa04920:Adipocytokine signaling pathway | 1 | 1 | 74 | 2 | 0 | 2 | 74 | 3174 |
| Ley_leukemia | hsa04912:GnRH signaling pathway | 1 | 1 | 116 | 2 | 0 | 2 | 116 | 3132 |
| Ley_leukemia | hsa04930:Type II diabetes mellitus | 1 | 1 | 51 | 2 | 0 | 2 | 51 | 3197 |
| Ley_leukemia | hsa04950:Maturity onset diabetes of the young | 1 | 1 | 18 | 2 | 0 | 2 | 18 | 3230 |
| Ley_leukemia | hsa04610:Complement and coagulation cascades | 1 | 1 | 78 | 2 | 0 | 2 | 78 | 3170 |
| Ley_leukemia | hsa04512:ECM-receptor interaction | 1 | 1 | 80 | 2 | 0 | 2 | 80 | 3168 |
| Ley_leukemia | hsa04010:MAPK signaling pathway | 1 | 1 | 279 | 2 | 0 | 2 | 279 | 2969 |
| Ley_leukemia | hsa04540:Gap junction | 1 | 1 | 105 | 2 | 0 | 2 | 105 | 3143 |
| Ley_leukemia | hsa04810:Regulation of actin cytoskeleton | 1 | 1 | 236 | 2 | 0 | 2 | 236 | 3012 |
| Ley_leukemia | hsa04650:Natural killer cell mediated cytotoxicity | 1 | 1 | 145 | 2 | 0 | 2 | 145 | 3103 |
| Ley_leukemia | hsa04530:Tight junction | 1 | 1 | 126 | 2 | 0 | 2 | 126 | 3122 |
| Ley_leukemia | hsa04730:Long-term depression | 1 | 1 | 96 | 2 | 0 | 2 | 96 | 3152 |
| Ley_leukemia | hsa04630:Jak-STAT signaling pathway | 1 | 1 | 141 | 2 | 0 | 2 | 141 | 3107 |
| Ley_leukemia | hsa04120:Ubiquitin mediated proteolysis | 1 | 1 | 121 | 2 | 0 | 2 | 121 | 3127 |
| Ley_leukemia | hsa04614:Renin-angiotensin system | 1 | 1 | 16 | 2 | 0 | 2 | 16 | 3232 |
| Ley_leukemia | hsa04310:Wnt signaling pathway | 1 | 1 | 147 | 2 | 0 | 2 | 147 | 3101 |
| Ley_leukemia | hsa04916:Melanogenesis | 1 | 1 | 104 | 2 | 0 | 2 | 104 | 3144 |
| Ley_leukemia | hsa04740:Olfactory transduction | 1 | 1 | 20 | 2 | 0 | 2 | 20 | 3228 |
| Ley_leukemia | hsa04742:Taste transduction | 1 | 1 | 23 | 2 | 0 | 2 | 23 | 3225 |
| Ley_leukemia | hsa04070:Phosphatidylinositol signaling system | 1 | 1 | 56 | 2 | 0 | 2 | 56 | 3192 |
| Ley_leukemia | hsa00440:Aminophosphonate metabolism | 1 | 1 | 10 | 2 | 0 | 2 | 10 | 3238 |
| Ley_leukemia | hsa00100:Biosynthesis of steroids | 1 | 1 | 11 | 2 | 0 | 2 | 11 | 3237 |
| Ley_leukemia | hsa00860:Porphyrin and chlorophyll metabolism | 1 | 1 | 13 | 2 | 0 | 2 | 13 | 3235 |
| Ley_leukemia | hsa04360:Axon guidance | 1 | 1 | 122 | 2 | 0 | 2 | 122 | 3126 |
| Ley_leukemia | hsa04140:Regulation of autophagy | 1 | 1 | 18 | 2 | 0 | 2 | 18 | 3230 |
| Ley_leukemia | hsa01430:Cell Communication | 1 | 1 | 94 | 2 | 0 | 2 | 94 | 3154 |
| Ley_leukemia | hsa04020:Calcium signaling pathway | 1 | 1 | 167 | 2 | 0 | 2 | 167 | 3081 |
| Ley_leukemia | hsa04514:Cell adhesion molecules (CAMs) | 1 | 1 | 116 | 2 | 0 | 2 | 116 | 3132 |
| Ley_leukemia | hsa00240:Pyrimidine metabolism | 1 | 1 | 54 | 2 | 0 | 2 | 54 | 3194 |
| Ley_leukemia | hsa05110:Cholera - Infection | 1 | 1 | 29 | 2 | 0 | 2 | 29 | 3219 |
| Ley_leukemia | hsa05217:Basal cell carcinoma | 1 | 1 | 52 | 2 | 0 | 2 | 52 | 3196 |
| Ley_leukemia | hsa00970:Aminoacyl-tRNA biosynthesis | 1 | 1 | 20 | 2 | 0 | 2 | 20 | 3228 |
| Ley_leukemia | hsa00626:Naphthalene and anthracene degradation | 1 | 1 | 10 | 2 | 0 | 2 | 10 | 3238 |
| Ley_leukemia | hsa00562:Inositol phosphate metabolism | 1 | 1 | 39 | 2 | 0 | 2 | 39 | 3209 |
| Ley_leukemia | hsa00710:Carbon fixation | 1 | 1 | 17 | 2 | 0 | 2 | 17 | 3231 |
| Ley_leukemia | hsa04940:Type I diabetes mellitus | 1 | 1 | 45 | 2 | 0 | 2 | 45 | 3203 |
| Ley_leukemia | hsa00052:Galactose metabolism | 1 | 1 | 17 | 2 | 0 | 2 | 17 | 3231 |
| Ley_leukemia | hsa00051:Fructose and mannose metabolism | 1 | 1 | 22 | 2 | 0 | 2 | 22 | 3226 |
| Ley_leukemia | hsa04612:Antigen processing and presentation | 1 | 1 | 79 | 2 | 0 | 2 | 79 | 3169 |
| Ley_leukemia | hsa00565:Ether lipid metabolism | 1 | 1 | 17 | 2 | 0 | 2 | 17 | 3231 |
| Ley_leukemia | hsa00632:Benzoate degradation via CoA ligation | 1 | 1 | 11 | 2 | 0 | 2 | 11 | 3237 |
| Ley_leukemia | hsa00251:Glutamate metabolism | 1 | 1 | 22 | 2 | 0 | 2 | 22 | 3226 |
| Ley_leukemia | hsa00010:Glycolysis / Gluconeogenesis | 1 | 1 | 40 | 2 | 0 | 2 | 40 | 3208 |
| Ley_leukemia | hsa00150:Androgen and estrogen metabolism | 1 | 1 | 14 | 2 | 0 | 2 | 14 | 3234 |
| Ley_leukemia | hsa00561:Glycerolipid metabolism | 1 | 1 | 19 | 2 | 0 | 2 | 19 | 3229 |
| Ley_leukemia | hsa00410:beta-Alanine metabolism | 1 | 1 | 11 | 2 | 0 | 2 | 11 | 3237 |
| Ley_leukemia | hsa00340:Histidine metabolism | 1 | 1 | 16 | 2 | 0 | 2 | 16 | 3232 |
| Ley_leukemia | hsa00030:Pentose phosphate pathway | 1 | 1 | 19 | 2 | 0 | 2 | 19 | 3229 |
| Ley_leukemia | hsa00220:Urea cycle and metabolism of amino groups | 1 | 1 | 14 | 2 | 0 | 2 | 14 | 3234 |
| Ley_leukemia | hsa00310:Lysine degradation | 1 | 1 | 25 | 2 | 0 | 2 | 25 | 3223 |
| Ley_leukemia | hsa00252:Alanine and aspartate metabolism | 1 | 1 | 21 | 2 | 0 | 2 | 21 | 3227 |
| Ley_leukemia | hsa00350:Tyrosine metabolism | 1 | 1 | 25 | 2 | 0 | 2 | 25 | 3223 |
| Ley_leukemia | hsa00450:Selenoamino acid metabolism | 1 | 1 | 13 | 2 | 0 | 2 | 13 | 3235 |
| Ley_leukemia | hsa03320:PPAR signaling pathway | 1 | 1 | 38 | 2 | 0 | 2 | 38 | 3210 |
| Ley_leukemia | hsa03010:Ribosome | 1 | 1 | 43 | 2 | 0 | 2 | 43 | 3205 |
| Ley_leukemia | hsa00930:Caprolactam degradation | 1 | 1 | 10 | 2 | 0 | 2 | 10 | 3238 |
| Ley_leukemia | hsa00910:Nitrogen metabolism | 1 | 1 | 13 | 2 | 0 | 2 | 13 | 3235 |
| Ley_leukemia | hsa00600:Sphingolipid metabolism | 1 | 1 | 21 | 2 | 0 | 2 | 21 | 3227 |
| Ley_leukemia | hsa00620:Pyruvate metabolism | 1 | 1 | 23 | 2 | 0 | 2 | 23 | 3225 |
| Ley_leukemia | hsa00230:Purine metabolism | 1 | 1 | 90 | 2 | 0 | 2 | 90 | 3158 |
| Ley_leukemia | hsa04340:Hedgehog signaling pathway | 1 | 1 | 51 | 2 | 0 | 2 | 51 | 3197 |
| Ley_leukemia | hsa04080:Neuroactive ligand-receptor interaction | 1 | 1 | 217 | 2 | 0 | 2 | 217 | 3031 |
| Ley_leukemia | hsa00360:Phenylalanine metabolism | 1 | 1 | 13 | 2 | 0 | 2 | 13 | 3235 |
| Ley_leukemia | hsa00500:Starch and sucrose metabolism | 1 | 1 | 38 | 2 | 0 | 2 | 38 | 3210 |
| Ley_leukemia | hsa00512:O-Glycan biosynthesis | 1 | 1 | 13 | 2 | 0 | 2 | 13 | 3235 |
| Ley_leukemia | hsa00591:Linoleic acid metabolism | 1 | 1 | 11 | 2 | 0 | 2 | 11 | 3237 |
| Ley_leukemia | hsa00790:Folate biosynthesis | 1 | 1 | 25 | 2 | 0 | 2 | 25 | 3223 |
| Ley_leukemia | hsa01032:Glycan structures - degradation | 1 | 1 | 17 | 2 | 0 | 2 | 17 | 3231 |
| Ley_leukemia | hsa00380:Tryptophan metabolism | 1 | 1 | 30 | 2 | 0 | 2 | 30 | 3218 |
| Ley_leukemia | hsa00511:N-Glycan degradation | 1 | 1 | 11 | 2 | 0 | 2 | 11 | 3237 |
| Ley_leukemia | hsa00071:Fatty acid metabolism | 1 | 1 | 18 | 2 | 0 | 2 | 18 | 3230 |
| Ley_leukemia | hsa00903:Limonene and pinene degradation | 1 | 1 | 13 | 2 | 0 | 2 | 13 | 3235 |
| Ley_leukemia | hsa00510:N-Glycan biosynthesis | 1 | 1 | 18 | 2 | 0 | 2 | 18 | 3230 |
| Ley_leukemia | hsa00564:Glycerophospholipid metabolism | 1 | 1 | 37 | 2 | 0 | 2 | 37 | 3211 |
| Ley_leukemia | hsa00280:Valine, leucine and isoleucine degradation | 1 | 1 | 14 | 2 | 0 | 2 | 14 | 3234 |
| Ley_leukemia | hsa00980:Metabolism of xenobiotics by cytochrome P450 | 1 | 1 | 17 | 2 | 0 | 2 | 17 | 3231 |
| Ley_leukemia | hsa00740:Riboflavin metabolism | 1 | 1 | 11 | 2 | 0 | 2 | 11 | 3237 |
| Ley_leukemia | hsa00020:Citrate cycle (TCA cycle) | 1 | 1 | 20 | 2 | 0 | 2 | 20 | 3228 |
| Ley_leukemia | hsa00361:gamma-Hexachlorocyclohexane degradation | 1 | 1 | 11 | 2 | 0 | 2 | 11 | 3237 |
| Ley_leukemia | hsa00640:Propanoate metabolism | 1 | 1 | 15 | 2 | 0 | 2 | 15 | 3233 |
| Ley_leukemia | hsa01031:Glycan structures - biosynthesis 2 | 1 | 1 | 19 | 2 | 0 | 2 | 19 | 3229 |
| Ley_leukemia | hsa00530:Aminosugars metabolism | 1 | 1 | 14 | 2 | 0 | 2 | 14 | 3234 |
| Ley_leukemia | hsa02010:ABC transporters - General | 1 | 1 | 21 | 2 | 0 | 2 | 21 | 3227 |
| Ley_leukemia | hsa00650:Butanoate metabolism | 1 | 1 | 18 | 2 | 0 | 2 | 18 | 3230 |
| Ley_leukemia | hsa00330:Arginine and proline metabolism | 1 | 1 | 23 | 2 | 0 | 2 | 23 | 3225 |
| Ley_leukemia | hsa00590:Arachidonic acid metabolism | 1 | 1 | 28 | 2 | 0 | 2 | 28 | 3220 |
| Ley_leukemia | hsa00260:Glycine, serine and threonine metabolism | 1 | 1 | 20 | 2 | 0 | 2 | 20 | 3228 |
| Ley_leukemia | hsa01030:Glycan structures - biosynthesis 1 | 1 | 1 | 39 | 2 | 0 | 2 | 39 | 3209 |
| Ley_leukemia | hsa00120:Bile acid biosynthesis | 1 | 1 | 10 | 2 | 0 | 2 | 10 | 3238 |
| Ley_leukemia | hsa00480:Glutathione metabolism | 1 | 1 | 18 | 2 | 0 | 2 | 18 | 3230 |
| Ley_leukemia | hsa00190:Oxidative phosphorylation | 1 | 1 | 56 | 2 | 0 | 2 | 56 | 3192 |